Novartis’ heart failure med Entresto wins FDA panel backing for bigger patient group—but just how much bigger?

Novartis’ heart failure med Entresto wins FDA panel backing for bigger patient group—but just how much bigger?
aliu
Wed, 12/16/2020 – 05:13